ES2043610T3 - Procedimiento para la produccion de un polipeptido hibrido del tipo activador de plasminogeno. - Google Patents

Procedimiento para la produccion de un polipeptido hibrido del tipo activador de plasminogeno.

Info

Publication number
ES2043610T3
ES2043610T3 ES87101209T ES87101209T ES2043610T3 ES 2043610 T3 ES2043610 T3 ES 2043610T3 ES 87101209 T ES87101209 T ES 87101209T ES 87101209 T ES87101209 T ES 87101209T ES 2043610 T3 ES2043610 T3 ES 2043610T3
Authority
ES
Spain
Prior art keywords
polypeptide
production
hybrid polypeptide
hybrid
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87101209T
Other languages
English (en)
Inventor
Michito Tagawa
Masakatsu Wada
Masayuki Yamada
Midori Yokoyama
Naganori Numao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Central Glass Co Ltd
Hodogaya Chemical Co Ltd
Nippon Soda Co Ltd
Nissan Chemical Corp
Sagami Chemical Research Institute
Tosoh Corp
Original Assignee
Central Glass Co Ltd
Hodogaya Chemical Co Ltd
Nippon Soda Co Ltd
Nissan Chemical Corp
Sagami Chemical Research Institute
Tosoh Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Central Glass Co Ltd, Hodogaya Chemical Co Ltd, Nippon Soda Co Ltd, Nissan Chemical Corp, Sagami Chemical Research Institute, Tosoh Corp filed Critical Central Glass Co Ltd
Application granted granted Critical
Publication of ES2043610T3 publication Critical patent/ES2043610T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

UN POLIPEPTIDO SIMILAR AL ACTIVADOR DEL PLASMINOGENO HIBRIDO QUE COMPRENDE UNA REGION DE POLIPEPTIDO RESPONSABLE DE UNA AFINIDAD A LA FIBRINA DERIVADA DE UN POLIPEPTIDO ACTIVADOR TISULAR DEL PLASMINOGENO Y UNA REGION DE POLIPEPTIDO RESPONSABLE DE UNA ACTIVIDAD ENZIMATICA DERIVADA DE UN POLIPEPTIDO DE PROUROQUINASA; UN SEGMENTO DE ADN DEL POLIPEPTIDO HIBRIDO; UN PLASMIDO QUE CONTIENE EL SEGMENTO DE ADN; UN MICROORGANISMO TRANSFORMADO CON EL ADN; Y UN PROCESO PARA LA PRODUCCION DEL POLIPEPTIDO HIBRIDO QUE COMPRENDE EL CULTIVO DEL MICROORGANISMO Y LA RECUPERACION DEL POLIPEPTIDO HIBRIDO DE LAS CELULAS CULTIVADAS.
ES87101209T 1986-01-31 1987-01-29 Procedimiento para la produccion de un polipeptido hibrido del tipo activador de plasminogeno. Expired - Lifetime ES2043610T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1773486 1986-01-31

Publications (1)

Publication Number Publication Date
ES2043610T3 true ES2043610T3 (es) 1994-01-01

Family

ID=11951975

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87101209T Expired - Lifetime ES2043610T3 (es) 1986-01-31 1987-01-29 Procedimiento para la produccion de un polipeptido hibrido del tipo activador de plasminogeno.

Country Status (7)

Country Link
EP (1) EP0231883B1 (es)
JP (1) JP2589687B2 (es)
DE (1) DE3781420T2 (es)
DK (1) DK175604B1 (es)
ES (1) ES2043610T3 (es)
SU (1) SU1732814A3 (es)
WO (1) WO1987004720A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4916071A (en) * 1985-08-14 1990-04-10 American Home Products Corporation Poly-kringle plasminogen activator
FI100106B (fi) * 1986-12-05 1997-09-30 Novartis Ag Menetelmä plasminogeenin yksisäikeisen yhdistelmäaktivaattorin valmist amiseksi
US5242819A (en) * 1986-12-05 1993-09-07 Ciba-Geigy Corporation DNA molecules encoding hybrid proteins of tissue plasminogen activator and urokinase
US5580559A (en) * 1986-12-05 1996-12-03 Ciba-Geigy Corporation Hybrid plasminogen activator
ZA879286B (en) * 1986-12-16 1988-10-26 Smith Kline Rit New plasminogen activators
WO1988005081A2 (en) * 1986-12-30 1988-07-14 Cetus Corporation Novel plasminogen activator
NL8700013A (nl) * 1987-01-06 1988-08-01 Leuven Res & Dev Vzw Hybride plasminogeenactivatoren met verbeterde trombolytische eigenschappen en geneesmiddelen die deze plasminogeenactivatoren bevatten.
NL8701021A (nl) * 1987-04-29 1988-11-16 Stichting Centraal Lab Humane t-pa(u-pa) substitutie-mutant eiwitten, daarvoor coderend recombinant dna, getransfecteerde gastheercellen, bereiding van de mutant eiwitten, en farmaceutische preparaten.
JP2561122B2 (ja) * 1988-04-13 1996-12-04 寳酒造株式会社 機能性ポリペプチド
JPH07143877A (ja) * 1993-10-01 1995-06-06 Sumitomo Pharmaceut Co Ltd 新規なｔ−ＰＡ類似体
EP4129334A4 (en) * 2020-03-31 2024-06-12 National Cancer Center FUSION PROTEIN FOR DISOLVING A FIBRIN CLOT AND PHARMACEUTICAL COMPOSITION CONTAINING SAID FUSION PROTEIN
TW202405178A (zh) * 2022-04-08 2024-02-01 日商凜研究所股份有限公司 與纖維蛋白結合的抗體及含有該抗體的纖維蛋白溶解性蛋白質以及含有該蛋白質的醫藥製劑

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL68561A (en) * 1982-05-05 1991-01-31 Genentech Inc Preparation of polypeptide with human tissue plasminogen activator function,processes for making it,and dna and transformed cell intermediates thereof
GB8314362D0 (en) * 1983-05-24 1983-06-29 Celltech Ltd Polypeptide and protein products
JPS60136520A (ja) * 1983-12-23 1985-07-20 Otsuka Pharmaceut Co Ltd フイブリン吸着性ウロキナ−ゼ複合体
GB8334498D0 (en) * 1983-12-24 1984-02-01 Beecham Group Plc Compounds

Also Published As

Publication number Publication date
DE3781420T2 (de) 1993-02-25
EP0231883B1 (en) 1992-09-02
SU1732814A3 (ru) 1992-05-07
WO1987004720A1 (en) 1987-08-13
DK50987D0 (da) 1987-01-30
DE3781420D1 (de) 1992-10-08
JP2589687B2 (ja) 1997-03-12
DK50987A (da) 1987-08-01
DK175604B1 (da) 2004-12-20
JPS62272975A (ja) 1987-11-27
EP0231883A1 (en) 1987-08-12

Similar Documents

Publication Publication Date Title
AR241314A1 (es) Aislado de adn, vector en base en dicho aislado cultivo de celulas tratadas con dicho vector y preparacion de factor viii humano funcional.
ES2043610T3 (es) Procedimiento para la produccion de un polipeptido hibrido del tipo activador de plasminogeno.
ES2169095T3 (es) Proteinas con actividad de factor viii, procedimiento para su produccion utilizando celulas modificadas por ingenieria genetica y composiciones farmaceuticas que los contienen.
ATE82588T1 (de) Zuchtverfahren fuer leukocyten.
ES2090297T3 (es) Produccion de proteinas que utilizan recombinacion homologa.
AR241654A1 (es) Procedimiento para producir activador de plasminogeno de tejido humano.
MX9304027A (es) Variante de al enzima lipasa y metodo para su produccion.
ATE85361T1 (de) Molekulare zuechtung.
DE3888642D1 (de) Rollflasche zur Züchtung von Zellengewebekulturen.
IL68366A (en) Process for expressing a gene encoding a protein comprising the enzymatic portion of human urokinase in a microorganism or cell culture
PT1318198E (pt) Processo para produzir um polipeptido recombinante que envolve a adicao de um inibidor de quimotripsina ao meio de cultura celular
ES2063015T3 (es) Proceso para la produccion de nuevos antibioticos, benanomicinas a y b y dexilosilbenanomicina b y usos de los mismos.
NO179754C (no) Fremgangsmåte for fremstilling av en t-PA-analog, DNA-sekveks som koder for t-PA-analogen, ekspresjonsvektor omfattende DNA-sekvensen samt vertscelle omfattende denne
ES2047033T3 (es) Un metodo para preparar compuestos de hidroxivitamina d.
ES2158684T3 (es) Procedimiento para la preparacion de acido 3,4-epoxibutirico quiral y sus sales.
ATE108831T1 (de) Rinder-interleukin-1-alpha.
IL130457A0 (en) Methods for producing parthenocarpic or female sterile transgenic plants and methods for enhancing fruit setting and development
ATE105862T1 (de) Methoden und materialien zur expression von varianten von menschlichem plasminogen.
FI921847A0 (fi) Farmaceutisk komposition som har endoproteolytisk aktivitet, foerfarande foer endoproteolytisk behandling av (prekursor)proteiner samt foerfarande foer (mikro)bio- logisk framstaellning av proteiner.
SE8702562L (sv) Nya fibrinolytiska enzymer
FI913266A0 (fi) Foerfarande foer infoerande av exogen dna i djurets somatiska och groddceller.
DK506683A (da) Fibrinolytiske enzymer, fremgangsmaader til fremstilling deraf og farmaceutiske midler indeholdende dem
KR890701733A (ko) 신규 인체 조직형 플리스미노겐 활성제 변이체
ES2123669T3 (es) Derivados del plasminogeno que se activan con trombina.
ES2056123T3 (es) Clonacion del gen que codifica la enzima isoamilasa y su empleo en la produccion de dicha enzima.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 231883

Country of ref document: ES